TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PSNL

Personalis Inc

Healthcare · Diagnostics & Research

16.40$ +1.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement PSNL
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
124.9% 68.7% 66.1% 74.4% 63.0% 79.5% 75.2% 68.3% 77.3%
-24.9% 31.3% 33.9% 25.6% 37.0% 20.5% 24.8% 31.7% 22.7%
105.6% 37.9% 34.4% 36.3% 57.7% 99.8% 88.2% 57.8% 72.2%
105.4% 29.8% 33.9% 42.8% 55.8% 98.3% 67.7% 54.6% 76.9%
211.0% 67.7% 68.2% 79.2% 113.5% 198.1% 155.8% 112.4% 149.1%
-236.0% -36.5% -34.4% -53.6% -76.4% -177.6% -131.0% -80.7% -126.4%
13.9% 5.0% 1.7% 0.0% 0.2% 0.3% 0.1% 0.0% 0.3%
-251.2% -52.6% -38.5% -52.4% -76.3% -174.1% -147.3% -96.0% -116.7%
0.1% 0.0% 0.0% 0.1% 0.0% 0.1% 0.1% 0.0% 0.0%
-251.2% -52.6% -38.5% -52.5% -76.3% -174.2% -147.4% -96.1% -116.7%
-224.4% -39.5% -29.4% -45.1% -69.0% -160.9% -131.7% -83.1% -101.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?